An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.

Xu L, Korade Z, Rosado DA, Liu W, Lamberson CR, Porter NA
J Lipid Res. 2011 52 (6): 1222-33

PMID: 21402677 · PMCID: PMC3090243 · DOI:10.1194/jlr.M014498

The level of 7-dehydrocholesterol (7-DHC) is elevated in tissues and fluids of Smith-Lemli-Opitz syndrome (SLOS) patients due to defective 7-DHC reductase. Although over a dozen oxysterols have been identified from 7-DHC free radical oxidation in solution, oxysterol profiles in SLOS cells and tissues have never been studied. We report here the identification and complete characterization of a novel oxysterol, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), as a biomarker for 7-DHC oxidation in fibroblasts from SLOS patients and brain tissue from a SLOS mouse model. Deuterated (d₇)-standards of 7-DHC and DHCEO were synthesized from d₇-cholesterol. The presence of DHCEO in SLOS samples was supported by chemical derivatization in the presence of d₇-DHCEO standard followed by HPLC-MS or GC-MS analysis. Quantification of cholesterol, 7-DHC, and DHCEO was carried out by isotope dilution MS with the d₇-standards. The level of DHCEO was high and correlated well with the level of 7-DHC in all samples examined (R = 0.9851). Based on our in vitro studies in two different cell lines, the mechanism of formation of DHCEO that involves 5α,6α-epoxycholest-7-en-3β-ol, a primary free radical oxidation product of 7-DHC, and 7-cholesten-3β,5α,6β-triol is proposed. In a preliminary test, a pyrimidinol antioxidant was found to effectively suppress the formation of DHCEO in SLOS fibroblasts.

MeSH Terms (23)

Animals Antioxidants Biomarkers Brain Cell Line, Tumor Cholestenones Chromatography, High Pressure Liquid Chromatography, Liquid Dehydrocholesterols Disease Models, Animal Embryo, Mammalian Female Fibroblasts Humans Isotope Labeling Mass Spectrometry Mice Mice, Knockout Oxidation-Reduction Oxidoreductases Acting on CH-CH Group Donors Pregnancy Reference Standards Smith-Lemli-Opitz Syndrome

Connections (1)

This publication is referenced by other Labnodes entities: